Finance

Lists
45E:FRA
Natera Inc
€266.90
-4.68%
(-13.10) 1D
Aug 14, 10:00:00 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 45E...
Open
€266.90
High
€266.90
Low
€266.90
Mkt. cap
44.67B
Avg. vol.
12.00
Volume
0.00
52-wk high
€280.00
52-wk low
€158.00
No. of employees
6K
Open
€266.90
High
€266.90
Low
€266.90
Mkt. cap
44.67B
Avg. vol.
12.00
Volume
0.00
52-wk high
€280.00
52-wk low
€158.00
No. of employees
6K
News stories
From web sources and news partners
Profile
Natera, Inc. is a clinical genetic testing company based in Austin, Texas that specializes in non-invasive, cell-free DNA testing technology, with a focus on women's health, cancer, and organ health. Natera's proprietary technology combines novel molecular biology techniques with a suite of bioinformatics software that allows detection down to a single molecule in a tube of blood. Natera operates CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments in San Carlos, California and Austin, Texas. Wikipedia
About Natera Inc
CEOSteven Chapman
Employees6.14K
FoundedJan 1, 2004
HeadquartersAustin, Texas, United States
SectorBiotechnology
Websitenatera.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
592.18M
665.50M
696.64M
752.75M
Cost of goods sold
207.80M
220.07M
245.81M
267.56M
Cost of revenue
207.80M
220.07M
245.81M
267.56M
Research and development expenses
173.41M
175.19M
210.70M
228.07M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
308.55M
291.30M
320.74M
328.87M
Operating expense
481.96M
468.21M
537.15M
562.65M
Total operating expenses
689.76M
688.28M
782.96M
830.21M
Operating income
-97.58M
-22.78M
-86.32M
-77.46M
Other non operating income
-
-
-
-
EBT including unusual items
-87.34M
-13.33M
-84.81M
-67.23M
EBT excluding unusual items
-87.34M
-13.33M
-77.61M
-68.90M
Income tax expense
207.00K
-60.58M
283.00K
-261.00K
Effective tax rate
-0.24%
454.63%
-0.33%
0.39%
Other operating expenses
-
-
-
-
Net income
-87.54M
47.26M
-85.09M
-66.97M
Net profit margin
-14.78%
7.10%
-12.21%
-8.90%
Earnings per share
-0.64
0.36
-0.60
-0.47
Interest and investment income
11.28M
10.45M
9.60M
9.45M
Interest expense
-1.04M
-991.00K
-892.00K
-890.00K
Net interest expenses
10.24M
9.46M
8.71M
8.56M
Depreciation and amortization charges
-
-
-
-
EBITDA
-87.28M
-13.69M
-66.09M
-56.27M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps